Becton, Dickinson and Co. | BDX - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Abbott USD 52.06B 69M 2026-03
Agilent USD 6.91B 167M 2025-12
Align Technology USD 4.15B 100.27M 2026-03
AngioDynamics USD 176.33M 2.52M 2025-09
Avanos Medical USD 782.1M 3.9M 2026-03
Baxter International USD 6.04B 86M 2026-03
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Bio-Rad Laboratories USD 6.85B 602.3M 2026-03
Boston Scientific USD 25.86B 1.63B 2026-03
Cooper Companies USD 8.36B 124.7M 2025-12
Danaher USD 52.95B 415M 2026-03
Dentsply International USD 1.32B 21M 2026-03
Dexcom USD 2.96B 210.9M 2026-03
Edwards Lifesciences USD 10.33B 10.1M 2026-03
Globus Medical USD 4.73B 159.06M 2026-03
Insulet USD 1.3B 212.6M 2026-03
Integra LifeSciences USD 1.04B 1.06M 2026-03
Intuitive Surgical USD 17.47B 349.5M 2026-03
J&J USD 81.19B 358M 2026-03
Masimo USD 788.9M 67.7M 2026-03
Medtronic USD 48.99B 128M 2025-12
Solventum Corp USD 4.97B 80M 2026-03
Stryker USD 22.42B 635M 2025-12
Tandem Diabetes Care USD 132.4M 22.77M 2026-03
Teleflex USD 3.08B 40.33M 2026-03
Terumo JPY 1.58T 62.18B 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03